Long-term homoeoprophylaxis study in children in North America. Part Two: Safety of HP, review of immunological responses, and effects on general health outcomes

Keywords: adverse events, children’s health, developing immune systems, healthy immunological response, immunity, homoeoprophylaxis (HPx), infectious disease, nosodes, public health program, unvaccinated, vaccines, vaccination.

 

As published in Simila, Journal of The Australian Homoeopathic Association: Volume 31, Number 2. December 2019.

ABSTRACT

Introduction: The immunological response stimulated by infectious disease develops immunity. Childhood infectious diseases, when naturally contracted, gradually activate and mature immune systems. Both vaccination and the use of nosodes* for homoeoprophylaxis (HP)** aim to introduce infectious agents to activate disease-specific immunological responses and avoid possible risks of natural disease.[i],[ii],[iii] Both methodologies attenuate (weaken) the viral or bacterial agents to minimise the potential risk of too strong an immune system response.[iv] While vaccination comes with attended risks that sometimes are more violent than the actual disease,[v] HP offers a low-risk immunisation method as demonstrated by the production of mild, short-lived immunological responses as the desired response, and improved general health outcomes.

Part two: FHCi Long-term HPx study in children

xli.              Birch, K (2014). Vaccines and homoeoprophylaxis share the same history. https://freeandhealthychildren.org/2014/03/16/vaccines-and-homeoprophylaxis-history/ (Last viewed 4 October 2019).

xlii.             Hahnemann, S. “The Cure and Prevention of Scarlet Fever.” Lessor Writings. B Jain Publishers, New Delhi.

xliii.            Castro, D., Nogueira, G (1968). “Use of the nosode Meningococcinum as a preventative against meningitis.” Journal of the American Institute of Homeopathy. 4 (Dec.): 211-219.

xliv.            Plitnick, L (2013). Global regulatory guidelines for vaccines. Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics. https://www.sciencedirect.com/topics/neuroscience/attenuated-vaccine (Last viewed 4 October 2019)

xlv.             Pertussis (whooping cough) disease and vaccine quick facts. National Vaccine Information Center. https://www.nvic.org/vaccines-and-diseases/whooping-cough/quick-facts.aspx (Last viewed 4 October 2019)